TMEFF2 had previously been reported to be methylated in lung adenocarcinoma [71], and inactivation of DNA methyltransferase 1 in a breast cancer cell line reactivates methylated TMEFF2[72], suggesting its DNA methylation leads to silencing. The gene discussed is DNMT1; the disease is breast carcinoma.